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Aim of the Study. Citrus species is used in traditional medicine as medicinal herb in several Asian countries including Korea.
Flavonioids became known as various properties, such as anti-oxidants, anti-inﬂammation and anti-cancer, and so forth. The
present study, the anti-cancer eﬀect of ﬂavonioids isolated from Citrus aurantium L. in human gastric cancer AGS cells has been
investigated. Materials and Methods. The anti-proliferative activity was assayed using MTT assay. Cell cycle analysis was done
using ﬂow cytometry and apoptosis detection was done using by hoechst ﬂuorescent staining and Annexin V-propidium iodide
double staining. Western blot was used to detect the expression of protein related with cell cycle and apoptosis. Results.F l a v o n o i d s
isolated from Citrus aurantium L. have the eﬀect of anti proliferation on AGS cells with IC50 value of 99μg/mL. Flavonoids
inhibited cell cycle progression in the G2/M phase and decrease expression level of cyclin B1, cdc 2, cdc 25c. Flavonoids induced
apoptosis through activate caspase and inactivate PARP. Conclusions. Flavonoids isolated from Citrus aurantium L. induced G2/M
phase arrest through the modulation of cell cycle related proteins and apoptosis through activation caspase. These ﬁnding suggest
ﬂavonoidsisolated from Citrus aurantium L. were useful agent for the chemoprevention of gastric cancer.
1.Introduction
Citrus fruits are a very popular food source because of their
nutrient, ﬂavor, and intrinsic attributes [1] and have long
been the basis of commonly used traditional medicines in
several Asian countries. Immature peels of citrus fruit are
used to treat indigestion and have demonstrated potential as
a chemotherapeutic agent [2, 3]. Among nutrients of citrus
fruits, ﬂavonoids have been more recently recognized as
having various medicinal beneﬁts that include antioxidant,
antimicrobial, anti-inﬂammatory, and anticancer activities
[4, 5]. Citrus fruits have numerous bioactive ﬂavonoids
such as naringin, naringenin, narirutin, nobiletin, quercetin,
kaempferol, hesperidin, neohesperidin, didymin, and pon-
cirin [6]. In particular, naringin, nobiletin, and hesperidin
display anticancer eﬀects via cell cycle arrest and apoptosis
[7–9].
Gastric cancer is the most prevalent cancer in Korea. Ac-
cording to Ministry of Health and Welfare statistics, there
were 28,078 cases of gastric cancer in Korea in 2008, repre-
senting 15.7% of all cancer cases in the country. Globally,
gastric cancer is the fourth leading cancer and is the second-
leading cause of cancer-related death, following lung can-
cer [10]. Treatment of gastric cancer consists generally of2 Evidence-Based Complementary and Alternative Medicine
surgery,chemotherapy,and/orradiotherapy.Whilethetreat-
ments can be eﬀective, about half of gastric cancer patients
are untreatable [11] .T h en e e df o rm o r ee ﬀective treatments
is pressing.
The programmed cell death mechanism of apoptosis is
the major regulator of cell proliferation and is a focus of
cancer research as an eﬀective way of eliminating precan-
cerous and/or cancerous cells [1]. Caspases play a pivotal
role in apoptosis; their overexpression and cleavage is a
precursor of apoptosis in mammalian cells. To date, 14
caspases have been identiﬁed based on their function. They
constitute three functional groups: inﬂammatory caspases
(caspase-1, -4, and -5), apoptotic initiator caspases (caspase-
2, -8, -9, and -10), and apoptotic eﬀector caspases (caspase-
3, -6, and -7) [12]. Caspases possess inactive zymogens that
consist of p20 (large) and p10 (small) subunits. In response
to apoptotic signals, the inactive zymogens are cleaved,
yielding active forms of the proteins that are associated with
the induction of apoptosis [13]. Also, the Bcl-2 family of
proteins, whose activity is directed to act at the mitochon-
drial outer membrane, are major regulators of apoptosis.
The Bcl-2 family consists of proapoptotic and antiapoptotic
members [14]. ApoptoticBcl-2proteins such as Bax and Bak
createdporesinthemitochondrialoutermembrane,through
which cytochrome c is released to the cytosol. Binding of
cytochrome c to Apaf-1 creates an apoptosome complex
that activates caspase-9, which in turn activates caspase-
3. Antiapoptotic Bcl-2 proteins such as Bcl-2 and Bcl-xL
preserve the mitochondrial membrane structure through
interaction with apoptotic Bcl-2 proteins [15].
Cell cycle arrest is also a major regulator of cell prolif-
eration. In eukaryotic cells, the cell cycle comprises the G1,
S, G2, and M phases. Checkpoints to the cycle are present
in the G1 and G2 phases. In cell cycle progression, cyclins
and cyclin-dependent kinases (cdks) play a central role as
regulators. In the mid-G1 phase, cell cycle progression is
controlled by a cyclin D-cdk4/cdk6 complex. In late-G1,
progression is controlled by the cyclin E-cdk2 complex. In
the G2 phase, cell cycle progression is controlled by the
cyclin A/B-cdc2 complex [16–18]. DNA damage can inhibit
cell proliferation by the inactivation of cyclins and cdks and
subsequent cell cycle arrest.
As referred to earlier, ﬂavonoids isolated from Citrus
aurantiumL.havetheanticancereﬀect.However,themecha-
nisms of the anticancer activity of Korea Citrus aurantium L.
still remain unknown. In the present study, we demonstrate
thatﬂavonoidsisolatedfromKoreaCitrus aurantium L.cause
cell cycle arrest and apoptosis in AGS human gastric cancer
cells. The expression levels of several important proteins are
showntobestrongly relatedwiththecellcycleandapoptosis.
Finally, the occurrence of cell cycle arrest and apoptosis was
determined to ascertain the anticancer mechanism of the
isolated ﬂavonoids.
2.Materialsand Methods
2.1. Antibodies and Reagents. Cyclin B1, cdc 2, cdc 25c, and
ß-actin were purchased from Millipore (Billerica,MA,USA).
Antibodies for Bcl-xL, Bax, cleaved poly(ADP-ribose) poly-
merase(PARP),andcaspases-3,-6,-8,and-9werepurchased
from Cell Signaling Technology (Danvers, Mass, USA).
Horseradish peroxidase- (HRP-) coupled goat anti-mouse
IgG and anti-rabbit IgG were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). RPMI-1640 was
purchased from Hyclone (Logan, UT, USA). Fetal bovine
serum (FBS) and antibiotics (streptomycin/penicillin) were
purchased fromGibco(BRLLifeTechnologies, GrandIsland,
NY, USA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-dephenyltetra-
zolium bromide (MTT), dimethylsulfoxide (DMSO), and
RNase A were obtained from Sigma-Aldrich (St. Louis,
MO, USA). Fluorescein isothiocyanate (FITC) annexin-V
apoptosis detection kit 1 was purchased from BD Pharmin-
gen (San Diego, CA, USA). Enhanced chemiluminescence
(ECL) kit was purchased from Amersham Life Science
(Buckinghamshire, UK). Materials and chemicals used for
electrophoresis were obtained from Bio-Rad Laboratories
(Hercules. CA, USA).
2.2. Isolation of Flavonoids. The analyses of isolation of ﬂa-
vonoids were conducted at the Department of Chemistry,
Gyeongsang National University by Professor Sung Chul
Shin. High-performance liquid chromatography (HPLC)
was performed as descried. Brieﬂy, HPLC analysis was
performed using a 1100 series LC system installed with a
G1322A degasser, a G1312A pump, a G1313A autosampler,
and a G1316A oven (Agilent Technologies, Palo Alto, CA,
USA). Chromatographic separation was carried out on
a Zorbax StableBond Analytical SB-C18 column (4.6 ×
250mm, 5μm; Agilent Technologies). The binary solvent
system was made up of 0.1% aqueous formic acid (A)
and methanol/acetonitrile (1:1) (B). Elution was performed
using a linear gradient (0%–25%B) over 10min and 40%–
70%B over 10min, followed by 30min of isocratic elution,
declined from 40%–25%B over 5min and followed by
10min of isocratic elution. The ﬂow rate was 0.5mL/min
in column temperature of 35◦C and an infusion volume
of 10μL in each experiment. Chromatographic data were
collected and controlled using a ChemStation, Rev.B.0301
(Agilent Technologies). Spectral data were collected (200–
400nm, 2nm resolution) for the entire progression, and the
ﬂavonoids were quantiﬁed by extracting each chromatogram
at 280nm (Figure 1). All ﬂavanones and ﬂavones were
quantiﬁed using the external calibration curvesof hesperetin
and nobiletin, respectively. Tandem mass spectrometry
(MS/MS) experiments were conducted using a 3200QTRAP
LC-MS/MS system (Applied Biosystems, Foster City, CA,
USA) with a Turbo V-source and a Turbo Ion Spray probe
(Applied Biosystems). The mass spectrometer was operated
i nt h ep o s i t i v em o d ew i t hs e l e c t e di o nm o n i t o r i n g( S I M ) ,
BioAnalyst, version 1.4.2 (AB Sciex, Zagreb, Croatia). The
electron spray voltage was set at 5.2kV and the source
temperature at 500◦C. The mass spectra were recorded
between m/z 100 and m/z 1000 with a step size of 0.06amu.
2.3. Cell Culture. AGS human gastric cancer cells obtained
from the Korea Cell Line Bank (Seoul, Korea) were culturedEvidence-Based Complementary and Alternative Medicine 3
1
2
3
4
56 7
8
9
10
11
12
13 14
280nm
10 20 30 40 50 (min)
0
200
400
600
800
1000
mAU
MWD1 A, Sig = 280.5, Ref = off (1214-CITRUS\1214-NAOH-C.D)
Figure 1: HPLC chromatogram patterns of Korea Citrus aurantium L. at 280nm. (1) naringin, (2) hesperidin, (3) poncirin, (4) isosi-
ennsetin, (5) hexamethoxyﬂavone, (6) sineesytin, (7) hexamethoxyﬂavone, (8) tetramrthnl-o-isoscutellaeein, (9) nobiletin, (10) hep-
tamethoxyﬂavone, (11) 3-hydoxynobiletin, (12) tangeretin, (13) hydroxypentamethoxyﬂavone, and (14) hexamethoxyﬂavone.
in RPMI-1640 medium supplemented with 10% heat-inac-
tivated fetal calf serum and 100μg/mL of penicillin and
streptomycin in a humidiﬁed atmosphere of 5% CO2 at
37◦C.
2.4. Cell Viability Assay and Morphological Examination.
Cell viability was determined using MTT 24h after the
experimental treatments. Brieﬂy, cells were plated in wells
of 12-well plates and incubated for 24h at 37◦C. The cells
were untreated or treated with varying concentrations of
ﬂavonoids(10,50,100,150,and200μg/mL)for24hat37◦C.
DMSO (0.1%) was used as a vehicle control. MTT solution
(5mg/mL in phosphate buﬀered saline; PBS) was diluted to
0.5mg/mL by medium. After 3h incubation at 37◦C, MTT-
containing medium was removed and the crystals that had
formed were dissolved by the addition of DMSO to each
well. After mixing, the absorbance of the cells was measured
at 540nm by using an enzyme-linked immunosorbent assay
plate reader. For morphological examination, cells were
grown on 6-well plates, treated with ﬂavonoids for 24h, and
then examined under light microscopy (×400).
2.5. Hoechst 33258 Fluorescent Staining. AGS cells from ex-
ponentially growing cultures were seeded in 12-well culture
plates. AGS cells were untreated or treated with varying
concentrations of ﬂavonoids (20, 40, 60, 80, and 100μg/mL)
for 24h at 37◦C. The cells were then washed in ice-cold
phosphate-buﬀered saline (PBS) and ﬁxed in a solution of
3.7% paraformaldehyde for 15min at room temperature.
To identify the apoptotic AGS cells, they were stained
with Hoechst 33258 (5μg/mL in PBS) for 10min at room
temperature. The nuclei structure of the cells was examined
by Leica ﬂuorescence microscopy. The apoptotic cells were
observed at 1000x magniﬁcation.
2.6. Cell Cycle Analysis. Upon reaching 70%–80% conﬂu-
ence, AGS cells were untreated or treated with varying
concentrations of ﬂavonoids (20, 40, 60, 80, and 100μg/mL)
for 24h at 37◦C. Then, the cells were washed twice with
cold PBS, trypsinized, and centrifuged. The cells were
ﬁxed in 70%(v/v) ethanol for 24h at 4◦C. The cells were
washed with PBS and stained with propidium iodide (PI;
50μg/mL) including RNase A (0.1mg/mL) in PBS (pH 7.4)
for30mininthedark.PI-stainedsampleswereanalyzedwith
a FACScan ﬂow cytometer (Becton Dickinson, San Jose, CA,
USA).Ineachsample,10,000cellsweresorted.Thedatawere
analyzed using CellQuest software (Becton Dickinson).
2.7. Apoptosis Assays. Apoptotic cells were detected using a
FITC annexin-V apoptosis detection kit 1 (BD Pharmingen,
San Diego, CA, USA). Brieﬂy, cells were untreated or
treated with varying concentrations of ﬂavonoids (20, 40,
60, 80, and 100μg/mL) for 24h at 37◦C. The cells were
trypsinized and washed with PBS. The washed cells were
resuspended in Annexin-V binding buﬀercontaining 10mM
HEPES/NaOH, pH 7.4, 140mM NaCl and 2.5mM CaCl2
according to the manufacturer’s protocol. The cells were
stained simultaneously with FITC-conjugated Annexin-V
and PI at room temperature for 15min in the dark, prior
to the addition of binding buﬀer. The apoptotic cells were
measured using a FACScan ﬂow cytometer. The cells were
sorted into intact cells (Annexin V− PI−), early apoptotic
cells (Annexin V+ PI−), late apoptotic cells (Annexin V+
PI+), and necrotic cells (Annexin V− PI+).4 Evidence-Based Complementary and Alternative Medicine
2.8. Caspase-3 Activity. Caspase-3-activity was determined
by a colorimetric assay using a caspase-3 activation kit ac-
cording to the protocol of the manufacturer (Millipore,
Billerica, MA, USA). In brief, the cells were lysed in the
supplied lysis buﬀer and incubated for 10min in an ice
bath. Then, the samples were centrifuged for 5 minutes
in a microcentrifuge (10,000×g). The supernatants were
collected and incubated with Assay buﬀer and Caspase-
3S u b s t r a t e( A c - D E V D - p N A )f o r1 ha t3 7 ◦C. The optical
density of the reaction mixture was quantiﬁed using an
enzyme-linked immunosorbent assay platereaderat405nm.
2.9. Western Blot Analysis. Protein concentration was deter-
mined using a Bradford assay (Bio-Rad). An equal protein
amount was separated by 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), and the
resolved proteins were transferred onto 0.45mm Immob-
ilon-P polyvinylidene ﬂuoride (PVDF) membranes (Milli-
pore). Each membrane was blockedwith TBST(10mM Tris-
HCl, pH 7.4, 150mM NaCl, 0.1% Tween-20) containing 5%
skin milk. Blocking was performed for 1h at room temper-
ature. Then, each membrane was incubated with primary
antibody (1:1000dilution) for overnight at 4◦C, washed ﬁve
times for 10 minutes each time with TBST, and incubated
with HRP-conjugated secondary antibody (1:2000dilution)
for 2h at room temperature. Each membrane was washed
5 times for 10 minutes each time with TBST. Protein bands
were visualized by ECL and Western Blotting Detection
Reagents and exposed to X-ray ﬁlms (Fuji, Tokyo, Japan).
Each band was analyzed using the Image J program (http://
rsb.info.nih.gov/).
2.10. Statistical Analysis. All experiments were performed
in triplicate. Results are expressed as the mean ± standard
deviation of at least three separate experiments. Statistical
analysis was determined by Student’s t-test using SPSS
version 10.0 for Window (SPSS, Chicago, IL, USA). A value
of P<0.05 was considered to be signiﬁcant.
3.Results
3.1. Flavonoids Inhibit Cell Viability. In order to estimate the
eﬀect of cell viability inhibition, we tested the cytotoxicity
of various concentrations (0–200μg/mL) of ﬂavonoids for
24 using the MTT assay. As shown in Figure 2, ﬂavonoids
inhibited cell viability in a dose-dependent manner. Com-
pared with the control group, the viability of cells treated
with ﬂavonoid concentrations of 100μg/mL declined by
about 48% after 24h (IC50 approximately 99μg/mL). Visual
observations revealed a dose-dependent change in cell shape
such as cell shrinkage.
3.2. Flavonoids Induce G2/M Phase Cell Cycle Arrest. As
shown in Figure 4, ﬂavonoids arrested the cell cycle in a
dose-dependent fashion at the G2/M phase. The S phase was
signiﬁcantly decreased in AGS cells treated with ﬂavonoid
concentrations of 60, 80, and 100μg/mL. Comparison of
control cells and cells treated with 100μg/mL of ﬂavonoids
for 24h revealedan increase in the G2/M phase from 34.29%
to 49.23% (P<0.01) and a decrease in the S phase from
29.54% to 18.95% (P<0.01). But, ﬂavonoids did not inﬂu-
ence the G0/G1 phase. These data indicated that ﬂavonoids
caused G2/M phase arrest in AGS cells.
3.3. Flavonoids Inhibit Expression of Cyclin B1, cdc 2, and cdc
25c. Cyclin B1, cdc 2, and cdc 25c are important proteins
related to the G2/M phase. G2/M phase was controlled by a
complexformedcyclinB1andcdc2;thecomplexisregulated
by cdc 25c. Because ﬂavonoids induce G2/M phase arrest
in AGS cells, we evaluated the expression of proteins that
regulate the G2/M phase transition using Western blot. As
shown in Figure 4, the protein levels of cyclin B1, cdc 2,
and cdc 25c decreased in a dose-dependent manner, with
signiﬁcant inhibition occurring at ﬂavonoid concentrations
of 80 and 100μg/mL. These data indicated that ﬂavonoids
reduce the expression of cyclin B1, cdc 2, and cdc 25c.
3.4.FlavonoidsInduce Apoptosis. Apoptosisisanotherreason
of inhibited cell proliferation. The induction of apoptosis
by ﬂavonoid exposure was presently assessed using Hoechst
staining and Annexin V-PI double staining. Treatment with
100μg/mL ﬂavonoids for 24h in AGS cells produced intense
Hoechst-positive staining for condensed nuclei indicative
of apoptosis (Figure 5(a)). Also treatment with 0, 20, 40,
60, 80, and 100μg/mL of the ﬂavonoids for 24h progres-
sively decreased the proportion of intact cells (Figure 5(b)),
coincident with a dose-dependent increase in apoptosis.
Comparison of control group cells and cells treated with
100μg/mL of the tested ﬂavonoids for 24h revealed a
decrease in prevalence of intact cells from 88.26% to 42.42%
(P<0.01). In contrast, early apoptotic cells increased from
10.29% to 48.07% (P<0.01), and late apoptotic cells
increased from 1.34% to 9.44% (P<0.05). These data
indicated that ﬂavonoids induced apoptosis in AGS cells.
3.5. Flavonoids Activate Caspases and Shift the Bax/Bcl-xL
Ratio. The observation that the ﬂavonoids induced apopto-
sis of AGS cells prompted an examination of the expression
levels of some apoptosis regulatory proteins, including Bcl-
xL, Bax, procaspase-3, -6, -8, and -9, and cleaved PARP. Bcl-
xL and Bax are majorproteins ofthemitochondria apoptosis
pathway. Western blot results showed that expression level of
Bcl-xL was decreased in a dose-dependent manner, whereas
the level of Bax increased. The eﬀect was the signiﬁcantly
increased Bax/Bcl-xL ratio in the presence of ﬂavonoid
concentrationsof60,80, and 100μg/mL (Figure 7).Caspases
are also major proteins of apoptosis. Presently, the levels
of procaspase-3, -6,-8, and -9 were diminished in a dose-
dependent manner (Figure 6(a)). The observation of dimin-
ished procaspase-3 expression prompted an examination of
caspase-3 -activity in AGS cells treated with ﬂavonoids.
Treatment with the ﬂanovoids signiﬁcantly increased cas-
pase-3 activity at 60, 80, and 100μg/mL (Figure 6(g)).Cleav-
age of PARP is the main hallmark for caspase-dependent
apoptosis. Cleaved PARP also increased in a dose-dependent
manner. The collective data favored the suggestion thatEvidence-Based Complementary and Alternative Medicine 5
0
20
40
60
80
100
120
0 10 50 100 150 200
Flavonoids (μg/mL)
C
e
l
l
v
i
a
b
i
l
i
t
y
(
%
o
f
c
o
n
t
r
o
l
)
(a)
0μg/mL
60μg/mL
40μg/mL 20μg/mL
100μg/mL 80μg/mL
(b)
Figure 2: Eﬀect of ﬂavonoids on the viability of AGS cells. (a) AGS cells were treated with various concentrations of the ﬂavonoids for
24h. Cell viability was then determined by an MTT assay. Cell viability is represented as the percentage relative absorbance compared to
the controls. (b) Morphology of cells treated with or without ﬂavonoids for 24h and examined under light microscopy (×400). Each value
represents the mean of three experiments.
ﬂavonoids induced apoptosis through a shift in Bax/Bcl-xL
ratio and the activation of caspases.
4.Discussionand Conclusions
Plant-derived herbal medicines have been used for a long
timeinseveralAsiancountries. Severalstudiesreported anti-
cancer activity in vitro using a natural herb extract [19, 20].
In recentyears, interest in ﬂavonoidsisolated from medicinal
herbs such as Silybum marianum, Alpinia oﬃcinarum, and
Hypericum perforatum has been increasing because of their
anticancer eﬀects on various cancer cells. Furthermore,
natural ﬂavonoids advantageously do not possess any side
eﬀects [21, 22]. In this study, the main ﬂavonoids isolated
from Citrus aurantium L. were naringin, nobiletin, and
hesperidin. These components confer superb anticancer
eﬀects that appear through cell cycle arrest and apoptosis in
various cancers [8, 9, 23]( Table 1).
In the present study, the anticancer eﬀects of ﬂavonoids
isolated from Citrus aurantium L. on AGS gastric carcinoma
cells were investigated. Viability and motility assays demon-
strated that ﬂavonoids suppressed proliferation of AGS
cells compared with untreated control cells. Regulating the
cell cycle and apoptosis is crucial to retaining homeostasis
between cell division and cell death [24].
Cell cycle aperiodicity is a classic feature of tumor cells
[25]. In the cell cycle, the G2/M checkpoint represents a
potential target for cancer therapy. When cells that contain
damaged DNA enter mitosis, the G2/M checkpoint helps
prevent cell cycle progression in an eﬀort to repair of DNA
that was damaged in late S or G2 phase [26]. Quercetin
suppresses the proliferation of human cervical cancer cells
by inducing G2/M phase cell cyclearrest [27]. Also, genistein
induces G2/M phase cell cycle arrest in nasopharyngeal car-
cinoma cells [28]. Presently, AGS cells treated with various
concentrations of ﬂavonoids accumulated mostly in the
G2/M phase in a dose-dependent manner, whereas the S
phase decreased. In terms of regulating the cell cycle, cdcs
and cyclins play a most inﬂuential role. The complex formed
between cyclin B and cdc 2 is crucial in the transition from
t h eG 2t oMp h a s e[ 29]. At the end of the G2 phase, cdc
2 is activated by dephosphorylation on Thr14/Tyr15 and
complexes with cyclin B. Cdc 25c is very important in cdc
2 activation. Phosphorylation of cdc 25c plays an important
part in irreversible G2/M phase arrest [30]. Presently, the
testedﬂavonoidsdownregulated cyclinB1,cdc2,and cdc25c
protein levels, which were required for the processing of the
G2/M phase. Flavonoids such as luteolin and licochalcone
A suppress the growth of AGS cells by blocking cell cycle
progression at the G2/M phases. In these phases, cyclin B,
cdc 2, and cdc 25c play critical roles. Similar eﬀects reported
that luteolin and licochalcone A induce the downregulation
oftheproductionofcyclinB,cdc2,and cdc25c[31, 32].The
collective previous and present results support a powerful
inhibitory eﬀect of cyclin B, cdc 2, and cdc 25c and provide
molecular evidence of the antiproliferative eﬀect directed at
G2/M phase arrest. Decrease of cyclin B1, cdc 2, and cdc 25c
expression might be a molecular mechanism through which
ﬂavonoids induce G2/M arrest (Figure 3).
Apoptosis is programmed cell death that can occur by
a variety of internal or external stimuli, and these signals
are controlled by two distinct pathways. One is an extrinsic
pathway (death receptor pathway), and the other is an
intrinsic pathway (mitochondria pathway) [33]. Caspases
have a major role in the extrinsic and intrinsic pathways of
apoptosis.Intheregulationofapoptosis,caspasesaredivided6 Evidence-Based Complementary and Alternative Medicine
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Figure 3: Flavonoids induce G2/M phage arrest on AGS cells. Flavonoids were treated with the indicated concentrations, and cells were
incubated for 24h. Cell cycle proportions were determined by ﬂow cytometry after staining with propidium iodide. (a) Flow cytometry of
cell cycle phase distribution. (b) Statistical analysis of cell cycle phase distribution. Each value represents the mean of three experiments;
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Figure 4: Flavonoids alter the expression of cell-cycle-related proteins cdc 2, cyclin B1, and cdc 25c. The expression of proteins was assessed
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Table 1: The quantitative value and the retention time of identiﬁed ﬂavonoids isolated from Citrus aurantium L.
No. Rt MS[M+H]+ Compound Quantity ± SD (mg/kg)
1 16.46 581 Naringin 299.2 ± 0.5
2 18.02 611 Hesperidin 210.3 ± 1.3
3 29.56 595 Poncirin 108.6 ± 1.1
4 41.67 373 Isosinensetin 30.4 ± 0.1
5 42.88 403 Hexamethoxyﬂavone 15.5 ± 0.05
6 43.40 373 Sinensetin 19.7 ± 0.1
7 44.60 403 Hexamethoxyﬂavone 23.6 ± 0.07
8 45.91 343 Tetramethyl-o-isoscutellarein 35.6 ± 0.1
9 46.52 403 Nobiletin 200.5 ± 0.1
10 47.50 433 Heptamethoxyﬂavone 168.9 ± 1.3
11 48.91 419 3-Hydroxynobiletin 28.7 ± 0.1
12 50.78 373 Tangeretin 81.5 ± 0.09
13 52.06 389 Hydroxypentamethoxyﬂavone 12.8 ± 0.04
14 52.72 403 Hexamethoxyﬂavone 7.0 ± 0.04
i n t ot w og r o u p s :i n i t i a t o rc a s p a s e s( c a s p a s e - 2 ,- 8 ,- 9 ,a n d
-10) and eﬀector caspases (caspase-3, -6, and -7). Initiator
caspases are activated as a result of protein complex forma-
tion, such as the death-inducing signaling complex (DISC)
and apoptosome [24, 34]. The eﬀector caspases-3 and -6
are activated through the extrinsic pathway that involves
caspase-8 that involves caspase-9. Caspase-3 is a prominent
eﬀectorthatcleavesthevariouselementsrelatedtoapoptosis.
Because of similarities in their substrate speciﬁcity, caspase-
6 is able to partially assume the functional role of caspase-3
[35, 36]. PARP, as a DNArepair enzyme, is activated by DNA
breaks and promotes the attachment of ADP-ribose poly-
mers to various nuclear factors, expediting repair. PARP is
an important factor for cell viability. But, the cleavage of
PARP helps cellular disassembly and is a marker of cells un-
dergoing apoptosis. During apoptosis, caspases induce PARP
cleavage and inactivation [37]. Caspase signaling is initiated
and proceeds by proteolytic autocatalysis and by cleavage of
downstream caspases and substrates such as PARP [24]. The
Bax/Bcl-xL ratio is a key factor of mitochondria pathway
apoptosis. Proapoptotic proteins, such as Bax, translocate to
the mitochondrial membrane and make the mitochondrial
outer membrane permeable. Antiapoptotic proteins, such
as Bcl-xL, maintain the mitochondrial membrane status
by the interactions between proapoptotic proteins [38].
Therefore, the equilibrium between the expression levels of8 Evidence-Based Complementary and Alternative Medicine
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pro- and antiapoptotic proteins is critical for cell survival or
death. Presently, apoptosis analysis showed that ﬂavonoids
promoteapoptosis.Especially,earlyapoptoticcellsincreased.
Apoptosis induced by ﬂavonoids was also consistent with
the observed changes in morphology. Flavonoids caused
downregulation of procaspase-3, -6, -8, and -9, which con-
sequently increased the activity of caspase-3. The activation
of caspase-3 induced PARP cleavage. In previous studies, the
ﬂanovoids genistein and eupatilin induced apoptosis in AGS
cells through the activation of caspase-3 and cleaved PARP
[39, 40]. Caspase-3 is a very important key of apoptosis and
has been recognized as the crucial executioner caspase. Also,
cleavage of PARP is a biochemical hallmark of apoptosis.
Consistent with this, the ﬂavonoids isolated from Korea
Citrus aurantium L. induced apoptosis by activating caspase-
3 and cleaving PARP.
In conclusion, ﬂavonoids can inhibit the proliferation of
AGS cells through both G2/M arrest via the modulation of
cell-cycle-related proteins, cyclin B1, cdc 2, and cdc 25c and
triggering of apoptosis via upregulation of caspase-3 activity
and cleavage of PARP. Although additional investigations are
needed to prove the anticancer eﬀects of ﬂavonoids, this
study highlights the application potential of ﬂavonoids iso-
lated from Korea Citrus aurantium L. in gastric cancer chem-
otherapy.
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